Associations of renal function with diabetic retinopathy and visual impairment in type 2 diabetes: A multicenter nationwide cross-sectional study

BACKGROUND Diabetic retinopathy (DR) separately has been noted as a major public health problem worldwide as well. Currently, many studies have demonstrated an association between diabetic nephropathy and DR in type 1 diabetes mellitus (T1DM) patients, but this association is less strong in T2DM. The evidence for an association between renal function and DR and visual impairment among T2DM patients is limited, particularly in the Asian population. AIM To assess the association between glomerular filtration rate (GFR) and DR, severe DR, and severe visual impairment among T2DM patients in Thailand. METHODS We conducted a nationwide cross-sectional study based on the DM/HT study of the Medical Research Network of the Consortium of Thai Medical Schools. This study evaluated adult T2DM patients from 831 public hospitals in Thailand in the year 2013. GFR was categorized into ≥ 90, 60-89, 30-59 and < 30 mL/min/1.73 m2. The association between GFR and DR, severe DR, and severe visual impairment were assessed using multivariate logistic regression. RESULTS A total of 13192 T2DM patients with available GFR were included in the analysis. The mean GFR was 66.9 ± 25.8 mL/min/1.73 m2. The prevalence of DR, proliferative DR, diabetic macular edema, and severe visual impairment were 12.4%, 1.8%, 0.2%, and 2.1%, respectively. Patients with GFR of 60-89, 30-59 and < 30 mL/min/1.73 m2 were significantly associated with increased DR and severe DR when compared with patients with GFR of ≥ 90 mL/min/1.73 m2. In addition, increased severe visual impairment was associated with GFR 30-59 and < 30 mL/min/1.73 m2. CONCLUSION Decreased GFR was independently associated with increased DR, severe DR, and severe visual impairment. GFR should be monitored in diabetic patients for DR awareness and prevention.

[1]  Stephanie J. Fonda,et al.  Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives , 2018, PloS one.

[2]  H. Chen,et al.  Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study , 2017, British Journal of Ophthalmology.

[3]  L. Flor,et al.  Burden of type 2 diabetes mellitus in Brazil. , 2017, Cadernos de saude publica.

[4]  C. Deerochanawong,et al.  Diabetes in Thailand: Status and Policy , 2016, Current Diabetes Reports.

[5]  T. Wong,et al.  Increased Burden of Vision Impairment and Eye Diseases in Persons with Chronic Kidney Disease — A Population-Based Study , 2016, EBioMedicine.

[6]  R. Holle,et al.  The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease: A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[7]  T. Wong,et al.  Serum Cystatin C, Markers of Chronic Kidney Disease, and Retinopathy in Persons with Diabetes , 2015, Journal of Diabetes Research.

[8]  Tien Yin Wong,et al.  The Association of Estimated Glomerular Filtration Rate With Diabetic Retinopathy and Macular Edema. , 2015, Investigative ophthalmology & visual science.

[9]  T. Wong,et al.  Is chronic kidney disease associated with diabetic retinopathy in Asian adults? 在亚洲成年人中慢性肾病与糖尿病视网膜病变相关吗? , 2014, Journal of diabetes.

[10]  Tien Yin Wong,et al.  Kidney and eye diseases: common risk factors, etiological mechanisms, and pathways. , 2014, Kidney international.

[11]  R. Kalyani,et al.  Epidemiology of Diabetes and Diabetes Complications in the Elderly: An Emerging Public Health Burden , 2013, Current Diabetes Reports.

[12]  A. Harries,et al.  The double burden of diabetes and tuberculosis - public health implications. , 2013, Diabetes research and clinical practice.

[13]  H R Taylor,et al.  Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[14]  C. Deerochanawong,et al.  Diabetes management in Thailand: a literature review of the burden, costs, and outcomes , 2013, Globalization and Health.

[15]  Xueqing Yu,et al.  Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis , 2013, Diabetologia.

[16]  R. Klein,et al.  The association of retinopathy and low GFR in type 2 diabetes. , 2012, Diabetes Research and Clinical Practice.

[17]  G. Zoppini,et al.  High prevalence of advanced retinopathy in patients with type 2 diabetes from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study. , 2012, Diabetes research and clinical practice.

[18]  L. Laviola,et al.  Rate and Determinants of Association Between Advanced Retinopathy and Chronic Kidney Disease in Patients With Type 2 Diabetes , 2012, Diabetes Care.

[19]  A. Go,et al.  Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. , 2012, Archives of ophthalmology.

[20]  Sobha Sivaprasad,et al.  Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. , 2012, Survey of ophthalmology.

[21]  M. Woodward,et al.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. , 2012, JAMA.

[22]  D. Tarng,et al.  More Impact of Microalbuminuria on Retinopathy Than Moderately Reduced GFR Among Type 2 Diabetic Patients , 2012, Diabetes Care.

[23]  M. Lynn,et al.  Vitamin D insufficiency in diabetic retinopathy. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  B. Klein,et al.  Global Prevalence and Major Risk Factors of Diabetic Retinopathy , 2012, Diabetes Care.

[25]  J. Shaw,et al.  IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. , 2011, Diabetes research and clinical practice.

[26]  Alan W. Stitt AGEs and diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[27]  Romero-Aroca Pedro,et al.  Prevalence and Relationship Between Diabetic Retinopathy and Nephropathy, and its Risk Factors in the North-East of Spain, a Population-Based Study , 2010, Ophthalmic epidemiology.

[28]  F. Dekker,et al.  Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[29]  M. Maguire,et al.  Prevalence of ocular fundus pathology in patients with chronic kidney disease. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[30]  Farid Zayeri,et al.  Prevalence of diabetic retinopathy in Tehran province: a population-based study , 2009, BMC ophthalmology.

[31]  H. Bergrem,et al.  Diabetic eye complications in a medium sized municipality in southwest Norway. , 2009, Acta ophthalmologica Scandinavica.

[32]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[33]  T. Vignesh,et al.  Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India , 2009, Postgraduate Medical Journal.

[34]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[35]  G. Wolf,et al.  Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus. , 2007, Clinical nephrology.

[36]  R. Klein,et al.  Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study. , 2007, Ophthalmology.

[37]  J. Glenn,et al.  Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes , 2007, Experimental diabetes research.

[38]  G. Wolf,et al.  Advanced glycation end products and the kidney. , 2005, American journal of physiology. Renal physiology.

[39]  J. Forrester,et al.  Epidemiology of diabetic retinopathy and macular oedema: a systematic review , 2004, Eye.

[40]  Wolfgang Rathmann,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[41]  M. Manaviat,et al.  Retinopathy and microalbuminuria in type II diabetic patients , 2004, BMC ophthalmology.

[42]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[43]  V. Mossine,et al.  The effect of UVA light on the anaerobic oxidation of ascorbic acid and the glycation of lens proteins. , 2003, Investigative ophthalmology & visual science.

[44]  I. G. Fantus,et al.  Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. , 2000, Diabetes.

[45]  J. Gross,et al.  Five-Year Prospective Study of Glomerular Filtration Rate and Albumin Excretion Rate in Normofiltering and Hyperfiltering Normoalbuminuric NIDDM Patients , 1996, Diabetes Care.

[46]  H. Hammes,et al.  Nerve Growth Factor Prevents Both Neuroretinal Programmed Cell Death and Capillary Pathology in Experimental Diabetes , 1995, Molecular medicine.

[47]  S. Pocock,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2008, Gaceta sanitaria.

[48]  Thanya Chetthakul,et al.  A survey study on diabetes management and complication status in primary care setting in Thailand. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.